GT199700123A - Sales dimesilato de los ligandos del neuropeptido y. - Google Patents

Sales dimesilato de los ligandos del neuropeptido y.

Info

Publication number
GT199700123A
GT199700123A GT199700123A GT199700123A GT199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A
Authority
GT
Guatemala
Prior art keywords
compound
neuropeptide
ligands
dimesylate
salts
Prior art date
Application number
GT199700123A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199700123A publication Critical patent/GT199700123A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GT199700123A 1996-11-26 1997-11-25 Sales dimesilato de los ligandos del neuropeptido y. GT199700123A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
GT199700123A true GT199700123A (es) 1999-05-19

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199700123A GT199700123A (es) 1996-11-26 1997-11-25 Sales dimesilato de los ligandos del neuropeptido y.

Country Status (23)

Country Link
US (1) US5914329A (cg-RX-API-DMAC7.html)
EP (1) EP0944611B1 (cg-RX-API-DMAC7.html)
JP (1) JP3120861B2 (cg-RX-API-DMAC7.html)
AP (1) AP9701148A0 (cg-RX-API-DMAC7.html)
AR (1) AR010304A1 (cg-RX-API-DMAC7.html)
AT (1) ATE257472T1 (cg-RX-API-DMAC7.html)
AU (1) AU4792497A (cg-RX-API-DMAC7.html)
BR (1) BR9713538A (cg-RX-API-DMAC7.html)
CA (1) CA2272927C (cg-RX-API-DMAC7.html)
DE (1) DE69727155T2 (cg-RX-API-DMAC7.html)
DK (1) DK0944611T3 (cg-RX-API-DMAC7.html)
ES (1) ES2213207T3 (cg-RX-API-DMAC7.html)
GT (1) GT199700123A (cg-RX-API-DMAC7.html)
HN (1) HN1997000154A (cg-RX-API-DMAC7.html)
HR (1) HRP970640A2 (cg-RX-API-DMAC7.html)
ID (1) ID18964A (cg-RX-API-DMAC7.html)
MA (1) MA26450A1 (cg-RX-API-DMAC7.html)
PA (1) PA8441701A1 (cg-RX-API-DMAC7.html)
PE (1) PE17099A1 (cg-RX-API-DMAC7.html)
PT (1) PT944611E (cg-RX-API-DMAC7.html)
TN (1) TNSN97191A1 (cg-RX-API-DMAC7.html)
WO (1) WO1998023603A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA9710587B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
EP2002827A2 (en) 2001-12-05 2008-12-17 The Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
WO2003057886A2 (en) 2002-01-09 2003-07-17 Arexis Ab Detection of mutations
KR100716389B1 (ko) * 2004-11-23 2007-05-11 동화약품공업주식회사 N-히드록시-4-{5-[4-(5-이소프로필-2-메틸-1,3-티아졸-4-일)페녹시]펜톡시}벤즈아미딘 2메탄술폰산염
EP1877076A4 (en) * 2005-04-15 2012-02-01 Regenertech Pty Ltd USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014307A1 (en) * 1994-11-07 1996-05-17 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
DE69727155D1 (de) 2004-02-12
DK0944611T3 (da) 2004-04-13
US5914329A (en) 1999-06-22
DE69727155T2 (de) 2004-07-08
HRP970640A2 (en) 1998-10-31
AP9701148A0 (en) 1998-01-31
EP0944611A1 (en) 1999-09-29
CA2272927A1 (en) 1998-06-04
JP3120861B2 (ja) 2000-12-25
ID18964A (id) 1998-05-28
WO1998023603A1 (en) 1998-06-04
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
ZA9710587B (en) 1999-05-25
ES2213207T3 (es) 2004-08-16
PT944611E (pt) 2004-04-30
MA26450A1 (fr) 2004-12-20
HN1997000154A (es) 1999-02-09
TNSN97191A1 (fr) 2005-03-15
AR010304A1 (es) 2000-06-07
JP2000505110A (ja) 2000-04-25
BR9713538A (cg-RX-API-DMAC7.html) 2000-03-21
EP0944611B1 (en) 2004-01-07
PA8441701A1 (es) 2000-05-24
ATE257472T1 (de) 2004-01-15
AU4792497A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
HN1997000079A (es) Analogos de indazol sustituido.
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
ES2162198T3 (es) Agentes estrogenos.
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
EA200000251A1 (ru) Производные резорцинола
ES2178676T3 (es) Compuestos de pirimidina substituidos y su empleo.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
HN1998000175A (es) Imidazotriazininas
ES2125377T3 (es) Azaheterociclicos triciclicos n-acilatados utiles como antagonistas de vasopresina.
ES2138977T3 (es) Agonistas muscarinicos.
ES2113767T3 (es) Compuestos de tipo ceramidas, su procedimiento de preparacion y su utilizacion en cosmetica o en dermatologia.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
HN1998000166A (es) Compuesto de benceno sustituido procedimiento para su preparacion y composiciones herbicidas y defoliantes que los contienen.
BR9811948A (pt) Secretores de hormÈnio do crescimento
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
MX9304524A (es) Nuevos derivados de indol y composiciones que los contienen.
HN1997000098A (es) Ccompuesto de indol 2, 3 sustituido como agentes antiinflamatorios y analgesicos.
ES2127524T3 (es) Derivados de benzamida como antagonistas de vasopresina.
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
UY28377A1 (es) Agentes terapeuticos
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
MX9301112A (es) Derivados de indol.
MX9300412A (es) Derivados de 1h-bencimidazol sustituidos con pirroloimidazolilo e imadazopiridinilo
ES2169101T3 (es) Compuesto de metaloceno.